Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.
Autor: | Holmøy, Trygve1,2 trygve.holmoy@medisin.uio.no, Beiske, Antonie G.3, Zarnovicky, Svetozar4, Myro, Aija Zuleron1, Røsjø, Egil1,2, Kerty, Emilia2,5 |
---|---|
Zdroj: | BMC Neurology. 10/18/2016, Vol. 16, p1-5. 5p. 1 Black and White Photograph. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |